Marc Frahm
Stock Analyst at TD Cowen
(0.17)
# 4,092
Out of 4,711 analysts
15
Total ratings
16.67%
Success rate
-29.64%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Marc Frahm
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TBPH Theravance Biopharma | Maintains: Hold | $10 → $9 | $9.59 | -6.15% | 3 | Aug 6, 2024 | |
| INCY Incyte | Maintains: Buy | $88 → $80 | $68.84 | +16.21% | 3 | May 1, 2024 | |
| SANA Sana Biotechnology | Initiates: Market Perform | n/a | $1.65 | - | 1 | Aug 14, 2023 | |
| CGEM Cullinan Therapeutics | Initiates: Outperform | n/a | $11.60 | - | 1 | Jun 15, 2023 | |
| XLO Xilio Therapeutics | Initiates: Outperform | n/a | $1.28 | - | 1 | Nov 16, 2021 | |
| NUVL Nuvalent | Initiates: Outperform | n/a | $84.22 | - | 1 | Aug 23, 2021 | |
| ELEV Elevation Oncology | Initiates: Outperform | n/a | $0.58 | - | 1 | Jul 20, 2021 | |
| JANX Janux Therapeutics | Initiates: Outperform | n/a | $56.83 | - | 1 | Jul 6, 2021 | |
| DAWN Day One Biopharmaceuticals | Initiates: Outperform | n/a | $12.79 | - | 1 | Jun 21, 2021 | |
| INZY Inozyme Pharma | Initiates: Outperform | n/a | $2.99 | - | 1 | Aug 18, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $2.22 | - | 1 | Feb 24, 2020 |
Theravance Biopharma
Aug 6, 2024
Maintains: Hold
Price Target: $10 → $9
Current: $9.59
Upside: -6.15%
Incyte
May 1, 2024
Maintains: Buy
Price Target: $88 → $80
Current: $68.84
Upside: +16.21%
Sana Biotechnology
Aug 14, 2023
Initiates: Market Perform
Price Target: n/a
Current: $1.65
Upside: -
Cullinan Therapeutics
Jun 15, 2023
Initiates: Outperform
Price Target: n/a
Current: $11.60
Upside: -
Xilio Therapeutics
Nov 16, 2021
Initiates: Outperform
Price Target: n/a
Current: $1.28
Upside: -
Nuvalent
Aug 23, 2021
Initiates: Outperform
Price Target: n/a
Current: $84.22
Upside: -
Elevation Oncology
Jul 20, 2021
Initiates: Outperform
Price Target: n/a
Current: $0.58
Upside: -
Janux Therapeutics
Jul 6, 2021
Initiates: Outperform
Price Target: n/a
Current: $56.83
Upside: -
Day One Biopharmaceuticals
Jun 21, 2021
Initiates: Outperform
Price Target: n/a
Current: $12.79
Upside: -
Inozyme Pharma
Aug 18, 2020
Initiates: Outperform
Price Target: n/a
Current: $2.99
Upside: -
Feb 24, 2020
Initiates: Outperform
Price Target: n/a
Current: $2.22
Upside: -